Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Cited by (107)

Items 101–107 of 107

1. Optimization of the tumor microenvironment and nanomedicine properties simultaneously to improve tumor therapy
   Zhang, Bo, Shi, Wei, Jiang, Ting, Wang, Lanting, Mei, Heng, Lu, Heng, Hu, Yu, Pang, Zhiqing · 2016 · Oncotarget
2. Perspectives on Hypoxia Signaling in Tumor Stroma
   Zhang, Yuqing, Coleman, Morgan, Brekken, Rolf A. · 2021 · Cancers
3. Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine
   Kirtane, Ameya R., Sadhukha, Tanmoy, Kim, Hyunjoon, Khanna, Vidhi, Koniar, Brenda, Panyam, Jayanth · 2017 · Cancer Research
4. Targeting tumor extracellular matrix with nanoparticles to circumvent therapeutic resistance
   Ding, Xinyue, Liang, Yiyu, Zhou, Siyuan, Wu, Yao, Sałata, Patricia, Mikolajczk-Martinez, Agata, Khosrawipour, Veria, Zhang, Zhiwen · 2025 · Journal of Controlled Release
5. The many microenvironments of ovarian cancer
   Micek, Hannah M., Visetsouk, Mike R., Fleszar, Andrew J., Kreeger, Pamela K. · 2020 · Advances in experimental medicine and biology
6. Current Status of Research on Losartan in Tumour Therapy
   Wang, Han, Yuan, Shuang, Wang, Hongjing · 2026 · Journal of Cellular and Molecular Medicine
7. siRNA Nanoparticle Delivery Strategies and Clinical Trial Advances in Tumor Therapy
   Wang, Pingjie, Gong, Jing, Xu, Yilin, Xia, Xinhua · 2026 · International Journal of Molecular Sciences